PPARGC1A coding variation may initiate impaired NEFA clearance during glucose challenge

Diabetologia

Volumn 50, Issue 3, 2007, Pages 569-573

  Franks, P W ^a,b   Ekelund, U ^b   Brage, S ^b   Luan, J ^b   Schafer, A J ^c   O'Rahilly, S ^d   Barroso, I ^e   Wareham, N J ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^c Department of Life Sciences   (United States)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Body composition; Fatty acids; Genetics; Gly482Ser; PPARGC1A

Indexed keywords

FATTY ACID; GLUCOSE; GLYCINE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SERINE;

ADIPOSE TISSUE; ADULT; ALLELE; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DOWN REGULATION; DYSLIPIDEMIA; FATTY LIVER; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HEART; HETEROZYGOTE; HUMAN; LEAN BODY WEIGHT; LIPID METABOLISM; LIVER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SKELETAL MUSCLE;

ADIPOSE TISSUE; ADULT; AMINO ACID SUBSTITUTION; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE FREQUENCY; GENOTYPE; HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

EID: 33846828211     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0580-1     Document Type: Article

References (12)

1. Spiegelman BM, Puigserver P, Wu Z (2000) Regulation of adipogenesis and energy balance by PPARgamma and PGC-1. Int J Obes Relat Metab Disord 24(Suppl 4):S8-S10
2. Soyal S, Krempler F, Oberkofler H, Patsch W (2006) PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia 49:1477-1488
3. Mootha VK, Lindgren CM, Eriksson KF et al (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273
4. Ling C, Poulsen P, Carlsson E et al (2004) Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. J Clin Invest 114:1518-1526
5. Barroso I, Luan J, Sandhu M et al (2006) Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49:501-505
6. Muller YL, Bogardus C, Pedersen O, Baier L (2003) A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes 52:895-898
7. Ek J, Andersen G, Urhammer SA et al (2001) Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 44:2220-2226
8. Esterbauer H, Oberkofler H, Linnemayr Vet al (2002) Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women. Diabetes 51:1281-1286
9. Semple RK, Crowley VC, Sewter CP et al (2004) Expression of the thermogenic nuclear hormone receptor coactivator PGC-1alpha is reduced in the adipose tissue of morbidly obese subjects. Int J Obes Relat Metab Disord 28:176-179
10. Barroso I, Luan J, Middelberg RP et al (2003) Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol 1:E20
11. Lillioja S, Nyomba BL, Saad MF et al (1991) Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab 73:866-876
12. Hoeks J, Hesselink MK, Russell AP et al (2006) Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids. Diabetologia 49:2419-2426